Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.55 |
| ▸ | SENP1 | Q9P0U3 | 2/20 | 0.55 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.55 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.55 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14997154 | 1.00 | SENP2 (0.55) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL18044193 | 1.00 | SENP2 (0.55) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL14988777 | 0.99 | SENP2 (0.55) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL14988773 | 0.99 | SENP2 (0.55) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL15120211 | 0.92 | SENP2 (0.56) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL18044201 | 0.92 | SENP2 (0.56) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL29697142 | 0.92 | SENP2 (0.56) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL15120210 | 0.92 | SENP2 (0.60) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL18044289 | 0.92 | SENP2 (0.60) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL29697122 | 0.92 | SENP2 (0.60) | SENP2SENP1SUMO2SUMO1SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118434418-A | Composition for improving cardiac function | 国立大学法人京都大学 | 2024-08-02 | — | — | CN | claimed |
| CN-114599370-A | Pharmaceutical composition for protecting cartilage | 国立大学法人京都大学 | 2022-06-07 | — | — | CN | claimed |
| US-20250057823-A1 | COMPOSITION FOR IMPROVING CARDIAC FUNCTION | KYOTO UNIVERSITY (JP) | 2025-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057823-A1 | COMPOSITION FOR IMPROVING CARDIAC FUNCTION | TNNI3, NPPA, TNNT2 | SENP2 3538/4885SENP1 2852/4885SUMO2 4148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.